HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Harvard Apparatus Regenerative Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026
- Market cap
- $38.92M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.39 (+21.32%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Harvard Apparatus Regenerative Technology, Inc. grew revenue 44.6% to $982.00K over the twelve months to Jun 30, 2026.
Revenue
$982.00K
+44.6% vs. a year earlier
Operating income
-$6.71M
TTM Q2 2026
EPS, diluted
-$0.39
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $38.92M
- P/E ratio
- –
- Price to sales
- 39.64
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $982.00K
- Net income
- -$6.68M
- EPS, diluted
- -$0.39
- Book value per share
- -$0.08
- Diluted shares
- 18M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$982.00K+44.6% YoY
Gross profit
$74.00K-25.3% YoY
Operating income
-$6.71M
Net income
-$6.68M
EPS, diluted
-$0.39
Free cash flow
–
Reported periodTrailing twelve months